US FDA Objects to Ad for Takeda Pharmaceutical Co. Ltd.'s (Jobs) Rozerem Sleep Drug

March 9, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, March 8 (Reuters) - A Takeda Pharmaceutical Co. (4502.T: Quote, NEWS , Research) television commercial for insomnia drug Rozerem should have included information about its risks, U.S. regulators said in a letter released on Thursday.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research